Benefit/Risk Management Training Course, Prague, 19-20 May 2014
May 7, 2014
As Pharmacovigilance increasingly comes more into focus after the enactment of Article 57 (a) the benefit/risk balance of any given product provides the basis for all key decisions in the pharma industry from the commercial side and more importantly, from the regulatory bodies. It is therefore critical for all companies to understand and recognize the importance of Benefit/Risk Management.
It is for this reason that Dr. Jan Petracek and Dr. Jan-Willem van der Velden, two of Europe‘s foremost experts on the subject of Benefit/Risk Management, will be presenting an intensive training course on the subject of Benefit/Risk Management in Prague on 19th and 20th of May 2014.
The course is specifically designed for experienced PV professionals responsible for the design and maintenance of risk management systems as well as Qualified Persons for Pharmacovigilance (QPPVs) and the heads of benefit/risk management, patient safety, or life cycle management.
For the detailed agenda of the course and registration please view the attached program or go to DIA.
- Programme (PDF, 676.67 KiB)